{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T14:50:08Z","timestamp":1790607008484,"version":"4.1.0"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,30]],"date-time":"2023-11-30T00:00:00Z","timestamp":1701302400000},"content-version":"am","delay-in-days":302,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.neuropharm.2022.109336","type":"journal-article","created":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T18:30:13Z","timestamp":1668882613000},"page":"109336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["L-type calcium channel regulation of dopamine activity in the ventral tegmental area to nucleus accumbens pathway: Implications for substance use, mood disorders and co-morbidities"],"prefix":"10.1016","volume":"224","author":[{"given":"Eric J.","family":"Nunes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nii A.","family":"Addy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2022.109336_bib1","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1038\/s41386-018-0080-2","article-title":"The L-type calcium channel blocker, isradipine, attenuates cue-induced cocaine-seeking by enhancing dopaminergic activity in the ventral tegmental area to nucleus accumbens pathway","volume":"43","author":"Addy","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109336_bib2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nrm1155","article-title":"Calcium signalling: dynamics, homeostasis and remodelling","volume":"4","author":"Berridge","year":"2003","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neuropharm.2022.109336_bib3","article-title":"Effects of calcium channel antagonists on the reinforcing properties of morphine, ethanol and cocaine as measured by place conditioning","volume":"47","author":"Biala","year":"1996","journal-title":"J. Physiol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109336_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejphar.2006.03.017","article-title":"Reinstatement of nicotine-conditioned place preference by drug priming: effects of calcium channel antagonists","volume":"537","author":"Biala","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109336_bib5","first-page":"327","article-title":"Calcium channel antagonists suppress nicotine-induced place preference and locomotor sensitization in rodents","volume":"55","author":"Bia\u0142a","year":"2003","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109336_bib6","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jad.2008.10.003","article-title":"Self-medication of mood disorders with alcohol and drugs in the national epidemiologic survey on alcohol and related conditions","volume":"115","author":"Bolton","year":"2009","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109336_bib7","doi-asserted-by":"crossref","first-page":"6693","DOI":"10.1523\/JNEUROSCI.18-17-06693.1998","article-title":"L-Type calcium channels mediate a slow excitatory synaptic transmission in rat midbrain dopaminergic neurons","volume":"18","author":"Bonci","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109336_bib8","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1017\/S1461145709990368","article-title":"CaV1.3 L-type Ca2+ channels modulate depression-like behaviour in mice independent of deaf phenotype","volume":"13","author":"Busquet","year":"2010","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109336_bib9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1124\/pr.57.4.4","article-title":"International Union of Pharmacology. XLVII. Nomenclature and structure-function relationships of voltage-gated sodium channels","volume":"57","author":"Catterall","year":"2005","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109336_bib10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11713","article-title":"Rapid regulation of depression-related behaviours by control of midbrain dopamine neurons","volume":"493","author":"Chaudhury","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109336_bib11","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/mp.2016.86","article-title":"A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development","volume":"21","author":"Cipriani","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41380-022-01615-6","article-title":"Brain-penetrant calcium channel blockers are associated with a reduced incidence of neuropsychiatric disorders","author":"Colbourne","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib13","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0197-0186(02)00068-2","article-title":"The significance of action potential bursting in the brain reward circuit","volume":"41","author":"Cooper","year":"2002","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2022.109336_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.comppsych.2016.08.004","article-title":"Co-occurrence and symptomatology of fatigue and depression","volume":"71","author":"Corfield","year":"2016","journal-title":"Compr. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib15","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/npp.2017.123","article-title":"Cognitive characterization of schizophrenia risk variants involved in synaptic transmission: evidence of CACNA1C's role in working memory","volume":"42","author":"Cosgrove","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109336_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.biopsych.2010.06.019","article-title":"Mood disorder susceptibility gene CACNA1C modifies mood-related behaviors in mice and interacts with sex to influence behavior in mice and diagnosis in humans","volume":"68","author":"Dao","year":"2010","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib17","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/mp.2015.84","article-title":"L-type Ca2+ channel blockade with antihypertensive medication disrupts VTA synaptic plasticity and drug-associated contextual memory","volume":"21","author":"Degoulet","year":"2016","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib18","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/32448","article-title":"Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons","volume":"392","author":"Deisseroth","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109336_bib19","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1038\/sj.bjp.0706442","article-title":"A short history of voltage-gated calcium channels","volume":"147","author":"Dolphin","year":"2006","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2022.109336_bib20","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.neuropharm.2018.08.033","article-title":"Cav1.2 L-type calcium channels regulate stress coping behavior via serotonin neurons","volume":"144","author":"Ehlinger","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2022.109336_bib21","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0896-6273(00)81057-0","article-title":"Nomenclature of voltage-gated calcium channels","volume":"25","author":"Ertel","year":"2000","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109336_bib22","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nn1103","article-title":"Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission","volume":"6","author":"Floresco","year":"2003","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109336_bib23","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/syn.20651","article-title":"Plasticity of L\u2010type Ca2+ channels after cocaine withdrawal","volume":"63","author":"Ford","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2022.109336_bib24","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/mp.2013.107","article-title":"A rare mutation of CACNA1C in a patient with bipolar disorder, and decreased gene expression associated with a bipolar-associated common SNP of CACNA1C in brain","volume":"19","author":"Gershon","year":"2014","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib25","doi-asserted-by":"crossref","first-page":"17051","DOI":"10.1523\/JNEUROSCI.2255-10.2010","article-title":"Molecular switch from L-type Cav1. 3 to Cav1. 2 Ca2+ channel signaling underlies long-term psychostimulant-induced behavioral and molecular plasticity","volume":"30","author":"Giordano","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109336_bib26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.tins.2007.03.003","article-title":"Regulation of firing of dopaminergic neurons and control of goal-directed behaviors","volume":"30","author":"Grace","year":"2007","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109336_bib27","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1017\/S0033291715000537","article-title":"What is the impact of genome-wide supported risk variants for schizophrenia and bipolar disorder on brain structure and function? A systematic review","volume":"45","author":"Gurung","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2022.109336_bib28","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1080\/19336950.2021.1900024","article-title":"More than a pore: how voltage-gated calcium channels act on different levels of neuronal communication regulation","volume":"15","author":"Heck","year":"2021","journal-title":"Channels"},{"key":"10.1016\/j.neuropharm.2022.109336_bib29","doi-asserted-by":"crossref","first-page":"10247","DOI":"10.1523\/JNEUROSCI.1089-05.2005","article-title":"Neuronal L-type calcium channels open quickly and are inhibited slowly","volume":"25","author":"Helton","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109336_bib30","doi-asserted-by":"crossref","first-page":"9895","DOI":"10.1523\/JNEUROSCI.22-22-09895.2002","article-title":"Rewarding effects of the cholinergic agents carbachol and neostigmine in the posterior ventral tegmental area","volume":"22","author":"Ikemoto","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109336_bib31","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/01.jcp.0000115662.45074.c3","article-title":"Effects of isradipine on cocaine-induced subjective mood","volume":"24","author":"Johnson","year":"2004","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109336_bib32","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1017\/S1461145705005511","article-title":"Effects of isradipine on cocaine-induced changes in cognitive performance in recently abstinent cocaine-dependent individuals","volume":"8","author":"Johnson","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109336_bib33","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1113\/JP270673","article-title":"L\u2010type Ca2+ channels in mood, cognition and addiction: integrating human and rodent studies with a focus on behavioural endophenotypes","volume":"594","author":"Kabir","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2022.109336_bib34","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s13311-017-0532-0","article-title":"From gene to behavior: L-type calcium channel mechanisms underlying neuropsychiatric symptoms","volume":"14","author":"Kabir","year":"2017","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neuropharm.2022.109336_bib35","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1176\/ajp.142.11.1259","article-title":"The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence","volume":"142","author":"Khantzian","year":"1985","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib36","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0091-3057(92)90363-K","article-title":"Calcium antagonists isradipine and nimodipine suppress cocaine and morphine intravenous self-administration in drug-naive mice","volume":"41","author":"Kuzmin","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109336_bib37","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/mp.2012.71","article-title":"Forebrain elimination of cacna1c mediates anxiety-like behavior in mice","volume":"17","author":"Lee","year":"2012","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib38","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s002130000518","article-title":"Repeated stimulation of L-type calcium channels in the rat ventral tegmental area mimics the initiation of behavioral sensitization to cocaine","volume":"152","author":"Licata","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109336_bib39","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1471-4159.2003.01662.x","article-title":"The roles of calcium\/calmodulin\u2010dependent and Ras\/mitogen\u2010activated protein kinases in the development of psychostimulant\u2010induced behavioral sensitization","volume":"85","author":"Licata","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2022.109336_bib40","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1152\/jn.00486.2004","article-title":"L-type calcium channels: the low down","volume":"92","author":"Lipscombe","year":"2004","journal-title":"J. Neurophysiol."},{"issue":"14","key":"10.1016\/j.neuropharm.2022.109336_bib41","first-page":"1","article-title":"Impact of schizophrenia GWAS loci converge onto distinct pathways in cortical interneurons vs glutamatergic neurons during development","volume":"June","author":"Liu","year":"2022","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib42","doi-asserted-by":"crossref","first-page":"8594","DOI":"10.1074\/jbc.M610230200","article-title":"Calcium influx through L-type channels generates protein kinase M to induce burst firing of dopamine cells in the rat ventral tegmental area","volume":"282","author":"Liu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuropharm.2022.109336_bib43","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1152\/jn.00757.2013","article-title":"Cav1.2 and Cav1.3 L-type calcium channels regulate dopaminergic firing activity in the mouse ventral tegmental area","volume":"112","author":"Liu","year":"2014","journal-title":"J. Neurophysiol."},{"key":"10.1016\/j.neuropharm.2022.109336_bib44","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/02791072.1999.10471733","article-title":"Amlodipine treatment of cocaine dependence","volume":"31","author":"Malcolm","year":"1999","journal-title":"J. Psychoact. Drugs"},{"key":"10.1016\/j.neuropharm.2022.109336_bib45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jsat.2004.12.006","article-title":"A controlled trial of amlodipine for cocaine dependence: a negative report","volume":"28","author":"Malcolm","year":"2005","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.neuropharm.2022.109336_bib46","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/mp.2017.9","article-title":"Enhancing VTA Cav1.3 L-type Ca2+ channel activity promotes cocaine and mood-related behaviors via overlapping AMPA receptor mechanisms in the nucleus accumbens","volume":"22","author":"Mart\u00ednez-Rivera","year":"2017","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib47","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1523\/JNEUROSCI.20-01-00266.2000","article-title":"Critical dependence of cAMP response element-binding protein phosphorylation on L-type calcium channels supports a selective response to EPSPs in preference to action potentials","volume":"20","author":"Mermelstein","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109336_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF02316861","article-title":"Effects of nifedipine pretreatment on subjective and cardiovascular responses to intravenous cocaine in humans","volume":"105","author":"Muntaner","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109336_bib49","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.neuron.2018.03.017","article-title":"Calcium channels, synaptic plasticity, and neuropsychiatric disease","volume":"98","author":"Nanou","year":"2018","journal-title":"Neuron"},{"issue":"117 (3)","key":"10.1016\/j.neuropharm.2022.109336_bib50","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/jeab.747","article-title":"Cholinergic and dopaminergic-mediated motivated behavior in healthy states and in substance use and mood disorders","volume":"May","author":"Nunes","year":"2022","journal-title":"J. Exp. Anal. Behav."},{"key":"10.1016\/j.neuropharm.2022.109336_bib51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/bdi.12143","article-title":"Pilot investigation of isradipine in the treatment of bipolar depression motivated by genome\u2010wide association","volume":"16","author":"Ostacher","year":"2014","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neuropharm.2022.109336_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2020.106013","article-title":"Isradipine enhancement of virtual reality cue exposure for smoking cessation: rationale and study protocol for a double-blind randomized controlled trial","volume":"94","author":"Papini","year":"2020","journal-title":"Contemp. Clin. Trials"},{"key":"10.1016\/j.neuropharm.2022.109336_bib53","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/00004714-199810000-00009","article-title":"Nimodipine monotherapy and carbamazepine augmentation in patients with refractory recurrent affective illness","volume":"18","author":"Pazzaglia","year":"1998","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2022.109336_bib54","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0022-3565(24)37708-0","article-title":"Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine","volume":"286","author":"Pierce","year":"1998","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2022.109336_bib55","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/S0165-0173(97)00021-0","article-title":"A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants","volume":"25","author":"Pierce","year":"1997","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.neuropharm.2022.109336_bib56","doi-asserted-by":"crossref","first-page":"5839","DOI":"10.1113\/JP270672","article-title":"Ca(v) 1.3 (CACNA1D) L-type Ca(2+) channel dysfunction in CNS disorders","volume":"594","author":"Pinggera","year":"2016","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2022.109336_bib57","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1093\/hmg\/ddx175","article-title":"New gain-of-function mutation shows CACNA1D as recurrently mutated gene in autism spectrum disorders and epilepsy","volume":"26","author":"Pinggera","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2022.109336_bib58","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.biopsych.2014.11.020","article-title":"CACNA1D de novo mutations in autism spectrum disorders activate Cav1. 3 L-type calcium channels","volume":"77","author":"Pinggera","year":"2015","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib59","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1037\/1064-1297.13.4.319","article-title":"Effects of repeated-dose isradipine on the abuse liability of cocaine","volume":"13","author":"Roache","year":"2005","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2022.109336_bib60","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/archgenpsychiatry.2011.75","article-title":"Role of self-medication in the development of comorbid anxiety and substance use disorders: a longitudinal investigation","volume":"68","author":"Robinson","year":"2011","journal-title":"Arch. Gen. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib61","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.biopsych.2016.07.012","article-title":"Connectome disconnectivity and cortical gene expression in patients with schizophrenia","volume":"81","author":"Romme","year":"2017","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib62","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1177\/00048674211054740","article-title":"Comorbidity between mood and substance-related disorders: a systematic review and meta-analysis","volume":"56","author":"Saha","year":"2022","journal-title":"Aust. N. Z. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib63","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","article-title":"The mysterious motivational functions of mesolimbic dopamine","volume":"76","author":"Salamone","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109336_bib64","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jad.2018.10.089","article-title":"Disentangling the association of depression on the anti-fatigue effects of ketamine","volume":"244","author":"Saligan","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neuropharm.2022.109336_bib65","doi-asserted-by":"crossref","first-page":"13989","DOI":"10.1523\/JNEUROSCI.0450-13.2013","article-title":"Cue-evoked cocaine \u201ccraving\u201d: role of dopamine in the accumbens core","volume":"33","author":"Saunders","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109336_bib66","doi-asserted-by":"crossref","first-page":"13562","DOI":"10.1523\/JNEUROSCI.2315-11.2011","article-title":"Cav1. 2 L-type Ca2+ channels mediate cocaine-induced GluA1 trafficking in the nucleus accumbens, a long-term adaptation dependent on ventral tegmental area Cav1. 3 channels","volume":"31","author":"Schierberl","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109336_bib67","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.neuro.28.061604.135722","article-title":"Multiple dopamine functions at different time courses","volume":"30","author":"Schultz","year":"2007","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109336_bib68","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.cobeha.2015.09.006","article-title":"Phasic dopamine signals: from subjective reward value to formal economic utility","volume":"5","author":"Schultz","year":"2015","journal-title":"Curr. Opin.Behav. Sci."},{"key":"10.1016\/j.neuropharm.2022.109336_bib69","doi-asserted-by":"crossref","DOI":"10.1097\/01.hjh.0000836888.12438.8e","article-title":"Isradipine for the treatment of acute severe hypertension in children","volume":"40","author":"Short","year":"2022","journal-title":"J. Hypertens."},{"key":"10.1016\/j.neuropharm.2022.109336_bib70","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/sj.mp.4002151","article-title":"Whole-genome association study of bipolar disorder","volume":"13","author":"Sklar","year":"2008","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib71","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0091-3057(03)00157-6","article-title":"Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans","volume":"75","author":"Sofuoglu","year":"2003","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109336_bib72","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/0091-3057(91)90157-W","article-title":"A clinical trial of nifedipine in schizophrenia and tardive dyskinesia","volume":"39","author":"Suddath","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2022.109336_bib73","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1038\/s41386-018-0116-7","article-title":"Harmony and heresy of an L-type calcium channel inhibitor: suppression of cocaine seeking via increased dopamine transmission in the nucleus accumbens","volume":"43","author":"Swinford-Jackson","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2022.109336_bib74","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0896-6273(93)90215-D","article-title":"Molecular localization of regions in the L-type calcium channel critical for dihydropyridine action","volume":"11","author":"Tang","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2022.109336_bib75","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/gbb.12371","article-title":"Reduced levels of C acna1c attenuate mesolimbic dopamine system function","volume":"16","author":"Terrillion","year":"2017","journal-title":"Gene Brain Behav."},{"key":"10.1016\/j.neuropharm.2022.109336_bib76","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1523\/JNEUROSCI.6459-11.2012","article-title":"Dopaminergic mechanisms of individual differences in human effort-based decision-making","volume":"32","author":"Treadway","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2022.109336_bib77","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/da.22771","article-title":"Self\u2010medication with alcohol or drugs for mood and anxiety disorders: a narrative review of the epidemiological literature","volume":"35","author":"Turner","year":"2018","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.neuropharm.2022.109336_bib78","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature11740","article-title":"Dopamine neurons modulate neural encoding and expression of depression-related behaviour","volume":"493","author":"Tye","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2022.109336_bib79","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2165\/11588970-000000000-00000","article-title":"Efficacy and tolerability of long-acting nifedipine GITS\/OROS monotherapy or combination therapy in hypertensive patients","volume":"31","author":"Ueng","year":"2011","journal-title":"Clin. Drug Invest."},{"key":"10.1016\/j.neuropharm.2022.109336_bib80","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biopsych.2004.07.007","article-title":"The reality of comorbidity: depression and drug abuse","volume":"56","author":"Volkow","year":"2004","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2022.109336_bib81","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/BF03020488","article-title":"Calcium channels\u2014basic aspects of their structure, function and gene encoding; anesthetic action on the channels\u2014a review","volume":"49","author":"Yamakage","year":"2002","journal-title":"Can. J. Anesth."},{"key":"10.1016\/j.neuropharm.2022.109336_bib82","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/pr.114.009654","article-title":"The physiology, pathology, and pharmacology of voltage-gated calcium channels and their future therapeutic potential","volume":"67","author":"Zamponi","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2022.109336_bib83","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1113\/jphysiol.2005.094722","article-title":"Carbachol induces burst firing of dopamine cells in the ventral tegmental area by promoting calcium entry through L\u2010type channels in the rat","volume":"568","author":"Zhang","year":"2005","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2022.109336_bib84","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1124\/mol.109.056317","article-title":"Controls of tonic and phasic dopamine transmission in the dorsal and ventral striatum","volume":"76","author":"Zhang","year":"2009","journal-title":"Mol. Pharmacol."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822003951?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390822003951?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:21:43Z","timestamp":1758439303000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390822003951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":84,"alternative-id":["S0028390822003951"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109336","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"L-type calcium channel regulation of dopamine activity in the ventral tegmental area to nucleus accumbens pathway: Implications for substance use, mood disorders and co-morbidities","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2022.109336","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109336"}}